Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,865 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Gout and hyperuricemia in young people.
Yamanaka H. Yamanaka H. Curr Opin Rheumatol. 2011 Mar;23(2):156-60. doi: 10.1097/BOR.0b013e3283432d35. Curr Opin Rheumatol. 2011. PMID: 21169841 Review.
Spinal tophaceous gout mimicking a spinal tumor.
Nakajima A, Kato Y, Yamanaka H, Ito T, Kamatani N. Nakajima A, et al. Among authors: yamanaka h. J Rheumatol. 2004 Jul;31(7):1459-60. J Rheumatol. 2004. PMID: 15229971 No abstract available.
Multiple extensor tendon ruptures caused by tophaceous gout.
Iwamoto T, Toki H, Ikari K, Yamanaka H, Momohara S. Iwamoto T, et al. Among authors: yamanaka h. Mod Rheumatol. 2010 Apr;20(2):210-2. doi: 10.1007/s10165-009-0258-x. Epub 2009 Dec 16. Mod Rheumatol. 2010. PMID: 20013296
An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y. Kamatani N, et al. Among authors: yamanaka h. J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S13-8. doi: 10.1097/RHU.0b013e31821d36cc. J Clin Rheumatol. 2011. PMID: 21654265 Clinical Trial.
Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y. Kamatani N, et al. Among authors: yamanaka h. J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S19-26. doi: 10.1097/RHU.0b013e31821d36de. J Clin Rheumatol. 2011. PMID: 21654266 Clinical Trial.
1,865 results